Scil Proteins is a biopharmaceutical company whose key value driver is its proprietary Affilin® drug discovery platform. Scil Proteins has longstanding expertise in protein manufacturing, and their certified GMP production facility generates revenue through long-term customer contracts.
Latest news: 11.08.2010:
Scil
Proteins announced that it has completed
the formation of its advisory board. The AB is comprised of two scientific experts
in the field, Dr. Andreas Menrad and Dr. Jürgen
Wahl, as well as the seasoned financial consultant, Rainer Kroell.Read more...
